New Oriental
EDU
57.30
+0.19
+0.33%
New Oriental
US · EDU
#1604 by market cap
Listed 2006
57.30
+0.19
+0.33%
Live - 5344 symbols - heartbeat 258s ago
· 2026-10-07 22:39
After-hours
57.30
0.00%
Overnight
57.31
+0.02%
- Market cap
- 8.88B
- P/E (TTM)i
- 19.10
- P/Bi
- 2.23
- EPSi
- 3.00
- Div yieldi
- 2.09%
- 52W posi
- 65%
Reader sentiment
Are you bullish or bearish on EDU?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.67, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +15.53% YoY
Margins
- Gross margin
- 54.64%
- Operating margin
- 11.36%
- Net margin
- 8.39%
Key ratios & quality
- PEG ratioi
- 0.49
- Altman Z-Scorei
- 2.67
PEG uses trailing P/E against the 3-year net income growth rate (38.89%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.10B | 3.58B | 4.28B | 3.11B | 3.00B | 4.31B | 4.90B | 5.66B |
| Gross profit | 1.72B | 1.99B | 2.24B | 1.35B | 1.59B | 2.26B | 2.72B | 3.09B |
| Selling & admin expenses | 1.41B | 1.59B | 2.09B | 2.33B | 1.40B | 1.91B | 2.23B | 2.45B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 307.15M | 399.00M | 149.06M | -982.51M | 190.05M | 350.43M | 488.55M | 643.25M |
| Pretax profit | 315.85M | 487.84M | 314.98M | -1.03B | 308.53M | 493.84M | 536.38M | 730.55M |
| Tax | 85.71M | 134.36M | 83.59M | 136.31M | 66.07M | 109.69M | 146.29M | 196.11M |
| Net profit | 227.85M | 354.86M | 230.02M | -1.22B | 235.36M | 325.22M | 375.83M | 516.66M |
| Basic EPS | 2 | 3 | 2 | -7 | 1 | 2 | 2 | 3 |
| Diluted EPS | 1.50 | 2.60 | 2.00 | -7.00 | 1.00 | 1.80 | 2.30 | 3.00 |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Revenue | 1.18B | 1.24B | 1.52B | 1.19B | 1.42B | 1.53B |
| Gross profit | 651.47M | 673.28M | 885.19M | 634.55M | 761.17M | 812.22M |
| Selling & admin expenses | 526.95M | 621.66M | 574.36M | 568.25M | 580.85M | 726.42M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 124.52M | 51.63M | 310.83M | 66.31M | 180.32M | 85.80M |
| Pretax profit | 153.40M | 9.89M | 339.22M | 87.21M | 199.99M | 104.13M |
| Tax | 52.58M | 1.54M | 91.54M | 24.47M | 54.72M | 25.38M |
| Net profit | 89.67M | 11.34M | 247.52M | 56.28M | 139.88M | 72.97M |
| Basic EPS | 1 | 0 | 2 | 0 | 1 | 4 |
| Diluted EPS | 0.50 | 0.40 | 1.50 | 0.30 | 0.80 | 3.90 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.47B | 3.76B | 6.57B | 4.47B | 4.41B | 5.39B | 5.19B | 5.83B |
| Cash & ST investments | 3.19B | 3.52B | 6.26B | 4.19B | 4.00B | 4.78B | 4.58B | 5.11B |
| Inventory | 29.05M | 31.32M | 31.18M | 27.93M | 52.69M | 92.81M | 80.88M | 105.80M |
| Total assets | 4.65B | 6.56B | 10.15B | 6.03B | 6.39B | 7.53B | 7.81B | 8.79B |
| Total current liabilities | 2.01B | 2.48B | 3.47B | 1.71B | 2.25B | 3.00B | 3.29B | 3.89B |
| Short-term debt | -- | 384.24M | 514.03M | 168.62M | 155.75M | 199.93M | 256.00M | 285.02M |
| Long-term debt | 96.46M | 117.88M | 297.63M | 65.39M | 14.65M | 14.40M | 14.40M | -- |
| Total liabilities | 2,121,462,000.00 | 3,687,074,000.00 | 5,132,877,000.00 | 2,241,142,000.00 | 2,577,670,000.00 | 3,482,659,000.00 | 3,851,767,000.00 | 4,467,604,000.00 |
| Total equity | 2.53B | 2.87B | 5.02B | 3.79B | 3.81B | 4.05B | 3.95B | 4.32B |
| Retained earnings | 1.65B | 1.99B | 2.25B | 1.07B | 1.23B | 1.51B | 1.77B | 2.03B |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Total current assets | 4.87B | 5.19B | 5.31B | 5.59B | 5.43B | 5.83B |
| Cash & ST investments | 4.29B | 4.58B | 4.67B | 4.94B | 4.80B | 5.11B |
| Inventory | 85.71M | 80.88M | 86.28M | 92.09M | 86.05M | 105.80M |
| Total assets | 7.45B | 7.81B | 8.01B | 8.29B | 8.24B | 8.79B |
| Total current liabilities | 2.94B | 3.29B | 3.21B | 3.55B | 3.28B | 3.89B |
| Short-term debt | 239.58M | 256.00M | 260.22M | 262.06M | 273.26M | 285.02M |
| Long-term debt | 14.40M | 14.40M | -- | -- | -- | -- |
| Total liabilities | 3,471,675,000.00 | 3,851,767,000.00 | 3,754,521,000.00 | 4,086,166,000.00 | 3,826,412,000.00 | 4,467,604,000.00 |
| Total equity | 3.98B | 3.95B | 4.26B | 4.20B | 4.42B | 4.32B |
| Retained earnings | -- | 1.77B | -- | -- | -- | 2.03B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 805.65M | 804.46M | 1.13B | -1.28B | 971.01M | 1.12B | 896.59M | 1.03B |
| Depreciation & amortization | 114.00M | 151.00M | 230.44M | 194.43M | 122.70M | 106.82M | 145.89M | 178.73M |
| Free cash flow | 528.77M | 494.91M | 693.74M | -1.43B | 827.96M | 839.26M | 637.38M | 780.17M |
| Dividends paid | -- | -- | -- | -- | 0 | 0 | -98.20M | -96.36M |
| Stock buybacks / issuance | 177.39M | 0 | 1.51B | 0 | -191.63M | -62.94M | -445.50M | -230.89M |
| Ending cash balance | 1.42B | 919.42M | 1.63B | 1.19B | 1.81B | 1.59B | 1.82B | 2.10B |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| Operating cash flow | 963.00K | 399.12M | 192.32M | 323.47M | -7.46M | 518.75M |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | 963.00K | 139.91M | 192.32M | 323.47M | -7.46M | 271.84M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 1.59B | 1.82B | 1.54B | 2.10B | 2.04B | 2.10B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 10.94 | 16.23 | 8.75 | -27.56 | 4.85 | 8.39 | 10.00 | 12.43 |
| ROA %i | 5.52 | 7.38 | 4.00 | -14.68 | 2.85 | 4.45 | 4.85 | 5.73 |
| ROIC %i | 7.39 | 9.29 | 4.13 | -22.29 | 2.08 | 4.48 | 6.40 | 9.01 |
| 5-year avg ROE %i | 15.84 | 15.64 | 13.97 | 4.90 | 2.64 | 2.13 | 0.88 | 1.62 |
| EBIT margin %i | 10.25 | 13.76 | 7.52 | -33.12 | 10.32 | 11.46 | 10.95 | 12.90 |
| FCF / sales %i | 17.08 | 13.83 | 16.22 | -- | 27.62 | 19.46 | 13.01 | 13.78 |
| Current ratioi | 1.73 | 1.52 | 1.89 | 2.62 | 1.96 | 1.80 | 1.58 | 1.50 |
| Quick ratioi | 1.63 | 1.44 | 1.84 | 2.52 | 1.84 | 1.66 | 1.45 | 1.38 |
| Debt / assetsi | 2.08 | 24.10 | 21.30 | 11.28 | 7.17 | 8.79 | 10.30 | 9.65 |
| LT debt / equityi | 4.09 | 43.75 | 33.55 | 13.81 | 8.40 | 12.25 | 14.96 | 14.14 |
| Interest coveragei | 196.57 | 106.43 | 47.68 | -253.94 | 437.39 | 1,658.18 | 1,725.71 | 26,092.04 |
| Revenue CAGR (3Y) %i | 27.95 | 25.75 | 20.45 | 0.09 | -5.73 | 0.29 | 16.42 | 23.61 |
| Net income CAGR (3Y) %i | 1.92 | 14.62 | 4.14 | -- | -24.58 | -2.54 | -- | 38.89 |
| FCF CAGR (3Y) %i | 4.76 | -1.44 | 7.30 | -- | 18.71 | 6.55 | -- | -1.96 |
| Line item | 2025-02 | 2025-05 | 2025-08 | 2025-11 | 2026-02 | 2026-05 |
|---|---|---|---|---|---|---|
| ROE %i | 10.36 | 10.00 | 9.27 | 10.03 | 10.81 | 12.43 |
| ROA %i | 5.35 | 4.85 | 4.67 | 4.78 | 5.35 | 5.73 |
| ROIC %i | 8.84 | 6.40 | 7.80 | 8.37 | 9.02 | 9.01 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.33 | 10.95 | 11.11 | 11.70 | 12.23 | 12.90 |
| FCF / sales %i | 12.33 | 13.01 | 12.96 | 12.77 | 12.06 | 13.78 |
| Current ratioi | 1.66 | 1.58 | 1.65 | 1.57 | 1.66 | 1.50 |
| Quick ratioi | 1.47 | 1.45 | 1.47 | 1.40 | 1.48 | 1.38 |
| Debt / assetsi | 9.92 | 10.30 | 9.78 | 9.41 | 9.79 | 9.65 |
| LT debt / equityi | 13.54 | 14.96 | 13.25 | 13.32 | 13.06 | 14.14 |
| Interest coveragei | -- | 1,725.71 | -- | -- | -- | 26,092.04 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Educational services and test preparation courses is the largest reported line at 70.77% of revenue, across 4 reported segments.
- The next-largest line, Private label products and livestreaming e-commerce, is a distant second at 14.25% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Educational services and test preparation courses70.77%
Private label products and livestreaming e-commerce14.25%
Overseas study consulting services9.03%
Others5.94%
Region
People's Republic of China (PRC)100.00%
Quote time 2026-10-07 22:39:27 · For reference only, not investment advice and not tailored to your situation.